• Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Contact Us
  • Site Map
  • Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
  • Media Center
  • News Releases
  • Publications

Press Releases

Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Dec 21, 2018
Lexicon Pharmaceuticals Announces Topline Phase 1 Clinical Results for LX2761 in Diabetes Dec 20, 2018
Lexicon Pharmaceuticals Announces Positive Topline Clinical Data for LX9211 Dec 18, 2018
FDA Advisory Committee to Review Investigational Sotagliflozin as Potential Treatment for Type 1 Diabetes Nov 29, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 08, 2018
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference Nov 06, 2018
Lexicon Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides a Business Update Nov 01, 2018
Lexicon Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on November 1, 2018 Oct 25, 2018
Lexicon Pharmaceuticals and Ipsen Biopharmaceuticals Canada Inc. Announce Health Canada Approval of Xermelo® (telotristat Ethyl) for the Treatment of Refractory Carcinoid Syndrome Diarrhea in Combination with Somatostatin Analog Therapy Oct 16, 2018
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 54th Annual Meeting Sep 24, 2018
  • 3
  • ...
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • 11
  • 12

Precision Science   »   Pioneering Medicine   »   Patient Driven

Thank you for your interest. Your e-mail will be added to our list for news alerts.
Sorry, our system is unable to handle this right now. Please contact us directly.
  • Home
  • About Us
  • Pipeline
  • Collaborations
  • Investors
  • Media Center
    • News Releases
    • Publications
  • Events
  • Careers
Copyright © 2020, Lexicon Pharmaceuticals, Inc. All Rights Reserved
  • Privacy Policy
  • Terms of Use
  • Vendor Terms
  • Contact Us
  • Sitemap